Imaging benign hepatocellular tumors: atypical forms and diagnostic traps.

[1]  Nancy A Obuchowski,et al.  Characteristics and distinguishing features of hepatocellular adenoma and focal nodular hyperplasia on gadoxetate disodium-enhanced MRI. , 2012, AJR. American journal of roentgenology.

[2]  J. Zucman‐Rossi,et al.  Role of contrast-enhanced sonography in differentiation of subtypes of hepatocellular adenoma: correlation with MRI findings. , 2012, AJR. American journal of roentgenology.

[3]  U. Motosugi,et al.  Hepatocellular adenoma and focal nodular hyperplasia: value of gadoxetic acid-enhanced MR imaging in differential diagnosis. , 2012, Radiology.

[4]  C. Park,et al.  Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease. , 2011, AJR. American journal of roentgenology.

[5]  H. Onaya,et al.  Ring-like enhancement of focal nodular hyperplasia with hepatobiliary-phase Gd-EOB-DTPA-enhanced magnetic resonance imaging: radiological-pathological correlation , 2011, Japanese Journal of Radiology.

[6]  S. Yoo,et al.  Gadoxetate disodium-enhanced hepatobiliary phase MRI of hepatocellular carcinoma: correlation with histological characteristics. , 2011, AJR. American journal of roentgenology.

[7]  N. Faccioli,et al.  Solid Hypervascular Liver Lesions: Accurate Identification of True Benign Lesions on Enhanced Dynamic and Hepatobiliary Phase Magnetic Resonance Imaging After Gadobenate Dimeglumine Administration , 2011, Investigative radiology.

[8]  M. Ronot,et al.  Hepatocellular adenomas: Accuracy of magnetic resonance imaging and liver biopsy in subtype classification , 2011, Hepatology.

[9]  Osamu Matsui,et al.  Hepatocellular carcinoma: signal intensity at gadoxetic acid-enhanced MR Imaging--correlation with molecular transporters and histopathologic features. , 2010, Radiology.

[10]  V. Paradis,et al.  A single-center surgical experience of 122 patients with single and multiple hepatocellular adenomas. , 2009, Gastroenterology.

[11]  V. Vilgrain,et al.  Characterization of focal liver lesions with SonoVue-enhanced sonography: international multicenter-study in comparison to CT and MRI. , 2009, World journal of gastroenterology.

[12]  J. Zucman‐Rossi,et al.  Hepatocellular adenoma management and phenotypic classification: The Bordeaux experience , 2009, Hepatology.

[13]  J. Correas,et al.  Échographie de contraste temps réel dans la prise en charge diagnostique des lésions nodulaires hépatiques : évaluation des performances diagnostiques et de l’impact économique sur une étude multicentrique française , 2009 .

[14]  B. Giraudeau,et al.  [Real-time contrast-enhanced ultrasound in the evaluation of focal liver lesions: diagnostic efficacy and economical issues from a French multicentric study]. , 2009, Journal de radiologie.

[15]  J. Zucman‐Rossi,et al.  Hepatocellular adenomas: Magnetic resonance imaging features as a function of molecular pathological classification , 2008, Hepatology.

[16]  T. Kim,et al.  Focal nodular hyperplasia and hepatic adenoma: differentiation with low-mechanical-index contrast-enhanced sonography. , 2008, AJR. American journal of roentgenology.

[17]  J. Zucman‐Rossi,et al.  Molecular pathogenesis of focal nodular hyperplasia and hepatocellular adenoma. , 2008, Journal of hepatology.

[18]  Cristel G. Thomas,et al.  Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry , 2007, Hepatology.

[19]  Sheng-Nan Lu,et al.  Contrast-enhanced ultrasonographic spoke-wheel sign in hepatic focal nodular hyperplasia. , 2006, European journal of radiology.

[20]  J. Zucman‐Rossi,et al.  Genotype–phenotype correlation in hepatocellular adenoma: New classification and relationship with HCC , 2006, Hepatology.

[21]  Roberto Passariello,et al.  Fat in the liver: diagnosis and characterization , 2006, European Radiology.

[22]  G. Morana,et al.  Accurate differentiation of focal nodular hyperplasia from hepatic adenoma at gadobenate dimeglumine-enhanced MR imaging: prospective study. , 2005, Radiology.

[23]  C. Dietrich.  Characterisation of focal liver lesions with contrast enhanced ultrasonography. , 2004, European journal of radiology.

[24]  J. Tran van Nhieu,et al.  MRI of atypical focal nodular hyperplasia of the liver: radiology-pathology correlation. , 2004, AJR. American journal of roentgenology.

[25]  J. H. Lim,et al.  Evaluation of Hepatic Focal Nodular Hyperplasia With Contrast‐Enhanced Gray Scale Harmonic Sonography , 2004, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[26]  R. Lencioni,et al.  Benign regenerative nodules in Budd-Chiari syndrome and other vascular disorders of the liver: radiologic-pathologic and clinical correlation. , 2002, Radiographics : a review publication of the Radiological Society of North America, Inc.

[27]  A. Luciani,et al.  Focal nodular hyperplasia of the liver in men: is presentation the same in men and women? , 2002, Gut.

[28]  H. Van Vlierberghe,et al.  CT and MR imaging findings in focal nodular hyperplasia of the liver: radiologic-pathologic correlation. , 2000, AJR. American journal of roentgenology.

[29]  K. Mortelé,et al.  Intratumoral steatosis in focal nodular hyperplasia coinciding with diffuse hepatic steatosis: CT and MRI findings with histologic correlation , 2000, Abdominal Imaging.

[30]  C. Degott,et al.  Focal nodular hyperplasia of the liver: a comprehensive pathologic study of 305 lesions and recognition of new histologic forms. , 1999, The American journal of surgical pathology.

[31]  A. Rahmouni,et al.  Management of focal nodular hyperplasia and hepatocellular adenoma in young women: A series of 41 patients with clinical, radiological, and pathological correlations , 1995, Hepatology.

[32]  E. Furth,et al.  Mr imaging of hepatic nodular regenerative hyperplasia , 1995, Journal of magnetic resonance imaging : JMRI.

[33]  M. Taupitz,et al.  Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging. , 1995, Radiology.

[34]  V. Vilgrain,et al.  Resection of presumed benign liver tumours , 1993, The British journal of surgery.

[35]  V. Vilgrain,et al.  Focal nodular hyperplasia of the liver: MR imaging and pathologic correlation in 37 patients. , 1992, Radiology.

[36]  A. Rahmouni,et al.  Focal nodular hyperplasia of the liver: assessment with contrast-enhanced TurboFLASH MR imaging. , 1991, Radiology.

[37]  L. Quint,et al.  MR imaging of hepatic focal nodular hyperplasia: characterization and distinction from primary malignant hepatic tumors. , 1987, AJR. American journal of roentgenology.